8-K - NIKA - Equibles

SECURITIES AND EXCHANGE

COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) of the SECURITIESEXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 22,

2022 (May 17, 2022)

NIKA PHARMACEUTICALS, INC.

(Exact Name of Registrant as Specified in Charter)

COLORADO	000-56234	90-0292940
(State or other jurisdiction of in Centennial Growth<br> Equities, Inc.)	(Commission File Number)	(IRS Employer Identification<br> No.)

2269 Merrimack Valley AvenueHenderson, NV 89044(Address

of principal executive offices) (Zip code)

(702)-326-3615Registrant's telephone number, including area

code:

CENTENNIAL GROWTH EQUITIES, INC.(Former Name or Former

Address, If Changed Since Last Report)

2269 Merrimack Valley AvenueHenderson, NV 89044

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

Section 5 - Corporate Governance and Management

Item 5.03 Amendments to Articles of Incorporation or Bylaws;Change in Fiscal Year

On May 14, 2022, at the Annual Shareholder Meeting of Centennial Growth Equities, Inc., the shareholders of the corporation resolved to amend the Bylaws and the Articles of Incorporation in order to reflect several resolutions voted by the majority of shareholders at the shareholder meeting.

On May 17, 2022, Centennial Growth Equities, Inc. filed an Amended and Restated Articles of Incorporation, which reflected a corporate name change from “CENTENNIAL GROWTH EQUITIES, INC.” to “NIKA PHARMACEUTICALS, INC.”, and an increase in the authorized common stock of the corporation from 90,000,000 at par value of $0.001 per share to 2,700,000,000 at par value of $0.001 per share.

On May 17, 2022, Centennial Growth Equities, Inc. filed the amended Bylaws of the corporation, which reflected the corporate name change to “NIKA PHARMACEUTICALS, INC.” and allowed for notice to the annual meetings of the shareholders via electronic mail and for the annual meetings of the shareholders to be conducted in online format at the discretion of the Board of Directors.

On August 19, 2022, Nika Pharmaceuticals, Inc. filed an Article of Amendment to reflect a change of the par value of the Corporation’s common stock and preferred stock from $0.001 to $0.0001 per share.

This summary is qualified in its entirety by reference to the Charter, the Bylaws, and Article of Amendment, copies of which are attached hereto as Exhibits 3.1, 3.2, 3.3 respectively, and are incorporated herein by reference.

(d) Exhibits. The following exhibits are filed herewith:

Exhibit
Number	Description
3.1	Articles of Amendment and Restatement of NIKA<br> PHARMACEUTICALS, INC. (formerly known as CENTENNIAL GROWTH EQUITIES, INC.)
3.2	Amended and Restated Bylaws of NIKA<br> PHARMACEUTICALS, INC. (formerly known as CENTENNIAL GROWTH EQUITIES, INC.)
3.3	Articles of Amendment of NIKA PHARMACEUTICALS,<br> INC. (formerly known as CENTENNIAL GROWTH EQUITIES, INC.)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized.

	CENTENNIAL GROWTH EQUITIES, INC.
Dated: August 22, 2022	By:	/s/ Dimitar Slavchev Savov
		Dimitar Slavchev Savov
		Chief Executive Officer,
		Director

NIKA PHARMACEUTICALS, INC. : Exhibit 3.1 - Filed by EDGARhub LLC

Document must be filed electronically.	Colorado Secretary of State
Paper documents are not accepted.	Date and Time: 05/17/2022 01:15 PM
Fees & forms are subject to change.	ID Number: 20041195123
For more information or to print copies	Document number: 20221492028
of filed documents, visit www.sos.state.co.	Amount Paid: $25.00

ABOVE SPACE FOR OFFICE USE ONLY

Amended and Restated Articles of Incorporation filed pursuant to §7-90-301, et seq. and §7-110-107 and §7-90-304.5 of the Colorado Revised Statutes (C.R.S.)

1.	For the entity, its ID number and<br> entity name are
	ID number	20041195123
		(Colorado Secretary of State ID number)
	Entity name	Centennial Growth Equities,Inc.
2.	The new entity name (if applicable) is	Nika Pharmaceuticals, Inc.
3.	The amended and restated constituent<br> filed document is attached.
4.	If the amendment provides for an<br> exchange, reclassification or cancellation of issued shares, the<br> attachment states the provisions for implementing the amendment.
5.	(Caution: Leave blank if the document does not have a delayed effective date. Stating a delayed effective date has significant legal<br> consequences. Read instructions before entering a date.)
	(If the following statement applies, adopt the statement by entering a date and, if applicable, time using the required format.)
	The delayed effective date and, if<br> applicable, time of this document is/are
			(mm/dd/yyyy hour:minute am/pm)

Notice:

Causing this document to be delivered to the Secretary of State for filing shall constitute the affirmation or acknowledgment of each individual causing such delivery, under penalties of perjury, that such document is such individual's act and deed, or that such individual in good faith believes such document is the act and deed of the person on whose behalf such individual is causing such document to be delivered for filing, taken in conformity with the requirements of part 3 of article 90 of title 7, C.R.S. and, if applicable, the constituent documents and the organic statutes, and that such individual in good faith believes the facts stated in such document are true and such document complies with the requirements of that Part, the constituent documents, and the organic statutes.

This perjury notice applies to each individual who causes this document to be delivered to the Secretary of State, whether or not such individual is identified in this document as one who has caused it to be delivered.


Redekop	Clifford
(Last)	(First)	(Middle)	(Suffix)
2269 Merrimack Valley Avenue
(Street name and number or Post Office Box information)
Henderson	NV	89044
(City)	(State)	(Postal/Zip Code)
	United States
(Province – if applicable)	(Country – if not US)

Page 1 of 2

(If the following statement applies, adopt the statement bymarking the box and include an attachment.)

☐ This document contains the true name and mailing address of one or more additional individuals causing the document to be delivered for filing.

Disclaimer:

This form/cover sheet, and any related instructions, are not intended to provide legal, business or tax advice, and are furnished without representation or warranty. While this form/cover sheet is believed to satisfy minimum legal requirements as of its revision date, compliance with applicable law, as the same may be amended from time to time, remains the responsibility of the user of this form/cover sheet. Questions should be addressed to the user’s legal, business or tax advisor(s).

Page 2 of 2

NIKA PHARMACEUTICALS, INC. : Exhibit 3.2 - Filed by EDGARhub LLC

NIKA PHARMACEUTICALS, INC. : Exhibit 3.3 - Filed by EDGARhub LLC

Document must be filed electronically.	Colorado Secretary of State
Paper documents are not accepted.	Date and Time: 08/19/2022 08:31 PM
Fees & forms are subject to change.	ID Number: 20041195123
For more information or to print copies	Document number: 20221797806
of filed documents, visit www.sos.state.co.us.	Amount Paid: $25.00